Attached files
file | filename |
---|---|
10-Q - QUARTERLY REPORT - Sonoma Pharmaceuticals, Inc. | v209780_10-q.htm |
EX-31.1 - CERTIFICATION OF CEO PURSUANT TO SECTION 302 - Sonoma Pharmaceuticals, Inc. | v209780_ex31-1.htm |
EX-10.47 - DISTRIBUTION AGREEMENT - Sonoma Pharmaceuticals, Inc. | v209780_ex10-47.htm |
EX-31.2 - CERTIFICATION OF CFO PURSUANT TO SECTION 302 - Sonoma Pharmaceuticals, Inc. | v209780_ex31-2.htm |
CERTIFICATION
PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
(18
U.S.C. SECTION 1350)
Pursuant
to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of
section 1350, chapter 63 of title 18, United States Code), the undersigned
officers of Oculus Innovative Sciences, Inc., a Delaware corporation (the
“Company”), do hereby certify, to such officers’ knowledge, that:
The
Quarterly Report on Form 10-Q for the quarter ended December 31, 2010 (the “Form
10-Q”) of the Company fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, and the information contained in
the Form 10-Q fairly presents, in all material respects, the financial condition
and results of operations of the Company.
Date:
February 4, 2010
|
By:
|
/s/
Hojabr Alimi
|
|
Hojabr
Alimi
|
|||
Chief
Executive Officer
|
|||
Date:
February 4, 2010
|
By:
|
/s/
Robert Miller
|
|
Robert
Miller
|
|||
Chief
Financial Officer
|
|||